2000
DOI: 10.1128/jvi.74.8.3924-3928.2000
|View full text |Cite
|
Sign up to set email alerts
|

Naturally Occurring TAP-Dependent Specific T-Cell Tolerance for a Variant of an Immunodominant Retroviral Cytotoxic T-Lymphocyte Epitope

Abstract: Upon immunization and restimulation with tumors induced by the endogenous AKR/Gross murine leukemia virus (MuLV), C57BL/6 mice generate vigorous H-2Kb -restricted cytotoxic T-lymphocyte (CTL) responses to a determinant (KSPWFTTL) derived from the p15E transmembrane portion of the viral envelope glycoprotein. By contrast, the highly homologous determinant RSPWFTTL, expressed by tumor cells induced by Friend/ Moloney/Rauscher (FMR) MuLV, is not immunogenic, even when presented to the immune system as vaccinia vi… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

1
7
0

Year Published

2001
2001
2020
2020

Publication Types

Select...
5
1

Relationship

2
4

Authors

Journals

citations
Cited by 6 publications
(8 citation statements)
references
References 31 publications
1
7
0
Order By: Relevance
“…Using well-defined primer pairs, we could not detect expression of AKV-gp70 mRNA in the thymus or spleen of BALB/c and B6 mice ( Figures 5 A and 5B). 29 , 31 , 37 However, retroviral gp70 mRNA was efficiently expressed in human and murine tumors and tumor cell lines, 38 for example, in the BALB/c-derived colon carcinoma CT26 29 and in B6-derived pancreatic ductal adenocarcinoma (AKC-5615 cells), established from a highly aggressive tumor in ATM-deficient AKC mice (Atm lox/lox ;Kras LSL-G12D/+ ;p48Cre; Atm lox/lox ( Figures 5 A and 5B). 39 To confirm that the expression of the RNA-binding tat domain in the stgp70tat antigen is sufficient to induce tumor-specific effector CD8 + T cell responses, we vaccinated B6 mice with pCI, pCI/stgp70, or pCI/stgp70tat DNA.…”
Section: Resultsmentioning
confidence: 99%
See 2 more Smart Citations
“…Using well-defined primer pairs, we could not detect expression of AKV-gp70 mRNA in the thymus or spleen of BALB/c and B6 mice ( Figures 5 A and 5B). 29 , 31 , 37 However, retroviral gp70 mRNA was efficiently expressed in human and murine tumors and tumor cell lines, 38 for example, in the BALB/c-derived colon carcinoma CT26 29 and in B6-derived pancreatic ductal adenocarcinoma (AKC-5615 cells), established from a highly aggressive tumor in ATM-deficient AKC mice (Atm lox/lox ;Kras LSL-G12D/+ ;p48Cre; Atm lox/lox ( Figures 5 A and 5B). 39 To confirm that the expression of the RNA-binding tat domain in the stgp70tat antigen is sufficient to induce tumor-specific effector CD8 + T cell responses, we vaccinated B6 mice with pCI, pCI/stgp70, or pCI/stgp70tat DNA.…”
Section: Resultsmentioning
confidence: 99%
“…gp70-specific PCRs were performed with the primer sets gp70/AKV (5′-CGA GCC AAA TAT AAA AGA GAA CCC-3′/5′-GGT GGT GAA CCA AGG GGA CTT-3′) and β-actin (5′-CAT GTT TGA GAC CTT CAA CAC CC-3′/5′-GCC ATC TCC TGC AAG TCT AG-3′) and additionally (623/7499 5′-GTA CGG GAT AGC ATG GCC AAA CTT AGA GAA-3′; 623/7694 5′-CTA CCG AAA TCC TGT CTT TGA TAA ACT G-3′). 31 All primers were purchased from biomers.net (Ulm, Germany). Cycling parameters were as follows: (I) 1 cycle: 95°C, 10 min; (II) 30 cycles: 95°C, 10 s, 53°C, 30 s, 72°C, 1 min; and (III) 72°C, 10 min.…”
Section: Methodsmentioning
confidence: 99%
See 1 more Smart Citation
“…Antigen Presentation Assays-Presentation of the SIINFEKL peptide was assessed using EL-4 cells treated in the presence or absence of P. aeruginosa (ϩCif) OMVs or (ϪCif) OMVs, then inoculated with PR8/SIINFEKL influenza at a multiplicity of infection of 10 and processed for flow cytometry by indirect labeling using the 25.D1-16 clone antibody to recognize specific K b -SIINFEKL complexes (12)(13)(14). Untreated cells were exposed in parallel with 1 nM OVA peptide as a positive control for 25.D1-16 clone antibody labeling.…”
Section: Methodsmentioning
confidence: 99%
“… 23 30 38 In contrast to Cr-1:K b /cr 16-24 , the gp70:K b /p15E epitope is not located in the ER-targeting SP (SP gp70 ) ( figure 2A ) and its processing/presentation apparently depends on proteasomal processing 39 and TAP. 38 Therefore, this antigen/epitope needs retrotranslocation from the ER to the cytosol and/or ‘cross-presentation’ for efficient MHC-I processing/presentation. 20 40 Neither full-length gp70 nor epitope-containing gp70 fragments induced CD8 T cells in H-2 d BALB/c or H-2 b B6 mice.…”
Section: Resultsmentioning
confidence: 99%